Imatinib Mesylate Alters the Expression of Genes Related to Disease Progression in an Animal Model of Uveal Melanoma

Imatinib mesylate (IM) is a compound that inhibits both BCR-ABL tyrosine kinase and c-kit receptors. Tyrosine kinases are important in cellular signaling and mediate major cellular processes such as proliferation, differentiation, apoptosis, attachment, and migration. Twenty-six albino rabbits were...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Anal Cell Pathol (Amst)
Autori principali: Fernandes, Bruno F., Di Cesare, Sebastian, Belfort, Rubens Neto, Maloney, Shawn, Martins, Claudia, Castiglione, Enzo, Isenberg, Jordan, Abourbih, Daniel, Antecka, Emilia, Burnier Jr., Miguel N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: IOS Press 2011
Soggetti:
Other
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605589/
https://ncbi.nlm.nih.gov/pubmed/21606571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ACP-2011-0010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi